Shiv Rao
Founder and CEO of Abridge, an AI-powered clinical documentation company.
“Shiv could build the team that took this like kernel of an idea that was directionally right and kind of wrong in the details to start and navigate it.”
Source→“Henry Kravis — Co-founder of KKR, investor in Abridge. Provided a pivotal reframe on the IPO question.”
Source→“Abridge was founded in 2018 but only became 'hot' around 2023 — a five-year wilderness walk.”
Source→“People, I think, in 2023 thought that was like last mile. That's actually most of it is that part. The model piece is much less.”
Source→“When you saw the announcements from OpenAI and Anthropic about forward deployed engineers and these partnerships with big private equity groups to go help their portfolios...”
Source→“Andy Weissman — Partner at Union Square Ventures. Led Abridge's seed round. Described as a foundational partner who invested pre-traction and pre-track-record.”
Source→“Rather than competing head-on with Microsoft (which acquired Nuance for $20B+), Abridge built from the conversation signal up into revenue cycle.”
Source→“There are doctors right now who we've heard who won't sign up to join a healthcare system, a hospital, if they don't have Abridge. It's one of those moments where all of a sudden, almost overnight, over the course of like three to four years, something just became table stakes.”
Source→“Shiv names him as the one investor he'd take with him if starting a new company.”
Source→“Joshua Wolfe (referenced as 'Joshua from Lux') — Co-founder of Lux Capital. Referenced for his 'chips on shoulders makes chips in pockets' aphorism.”
Source→“After an appointment, Abridge uses its proprietary models to generate a full medical note that's ready to drop into the patient's electronic health records, along with queues on follow-ups, test orders, or prescriptions.”
Source→“Identified as CEO of Abridge in the context of the HonorHealth deployment”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.